• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Understanding State-Level Variations in Implementing Academic Detailing for Prescribing Opioids: Findings from 11 States Within the United States.理解美国 11 个州在实施开处方类阿片药物学术强化方面的州级差异。
Pain Med. 2022 Sep 30;23(10):1644-1653. doi: 10.1093/pm/pnac039.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.受控物质处方模式 - 处方行为监测系统,八个州,2013 年。
MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1.
4
Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment.提供者对在实施国家学术细化项目后为有阿片类药物过量风险的患者开纳洛酮处方的障碍和促进因素的看法:定性评估。
Res Social Adm Pharm. 2020 Aug;16(8):1033-1040. doi: 10.1016/j.sapharm.2019.10.015. Epub 2019 Oct 31.
5
Impact of Implementing an Academic Detailing Program on Opioid-Benzodiazepine Co-Prescribing Trends at the U.S. Department of Veterans Affairs.实施学术细化项目对美国退伍军人事务部阿片类药物-苯二氮䓬类药物共同处方趋势的影响。
Pain Med. 2021 Jun 4;22(6):1426-1434. doi: 10.1093/pm/pnaa475.
6
Changing or validating physician opioid prescribing behaviors through audit and feedback and academic detailing interventions in primary care.通过审核与反馈以及在初级保健中进行学术推广干预来改变或验证医生的阿片类药物处方行为。
Implement Res Pract. 2025 Jan 7;6:26334895241307638. doi: 10.1177/26334895241307638. eCollection 2025 Jan-Dec.
7
The impact of community-level prevention strategies on high-dose opioid dispensing rates: 2014-2019.社区层面预防策略对高剂量阿片类药物配药率的影响:2014-2019 年。
Drug Alcohol Depend. 2021 Oct 1;227:108988. doi: 10.1016/j.drugalcdep.2021.108988. Epub 2021 Aug 27.
8
From the CDC: The Prevention for States program: Preventing opioid overdose through evidence-based intervention and innovation.美国疾病预防控制中心:预防药物过量国家项目:通过循证干预和创新预防阿片类药物过量。
J Safety Res. 2019 Feb;68:231-237. doi: 10.1016/j.jsr.2018.10.011. Epub 2018 Nov 4.
9
Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015.生命体征:2006 - 2015年美国阿片类药物处方的变化
MMWR Morb Mortal Wkly Rep. 2017 Jul 7;66(26):697-704. doi: 10.15585/mmwr.mm6626a4.
10
Exploring Providers' Perception to Naloxone Education for Opioid Overdose After Receiving Academic Detailing at the U.S. Department of Veterans Affairs.在美国退伍军人事务部接受学术详述后,探究医疗服务提供者对阿片类药物过量使用的纳洛酮教育的看法。
J Pharm Pract. 2023 Jun;36(3):514-522. doi: 10.1177/08971900211053282. Epub 2021 Nov 12.

引用本文的文献

1
Physicians' Self-Reported Knowledge and Behaviors Related to Prescribing Opioids for Chronic Pain and Diagnosing Opioid Use Disorder, DocStyles, 2020.医生自我报告的与慢性疼痛开具阿片类药物及诊断阿片类药物使用障碍相关的知识和行为,DocStyles,2020年
AJPM Focus. 2024 Aug 22;3(6):100269. doi: 10.1016/j.focus.2024.100269. eCollection 2024 Dec.

本文引用的文献

1
State-led opioid overdose prevention efforts: Challenges, solutions and lessons learned from the CDC Prevention for States Program (PfS).国家主导的阿片类药物过量预防工作:CDC 预防州计划(PfS)的挑战、解决方案和经验教训。
Subst Abus. 2021;42(2):227-235. doi: 10.1080/08897077.2021.1903649. Epub 2021 Apr 2.
2
Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019.2013-2019 年美国药物和合成阿片类药物过量死亡的趋势和地理模式。
MMWR Morb Mortal Wkly Rep. 2021 Feb 12;70(6):202-207. doi: 10.15585/mmwr.mm7006a4.
3
Educating community clinicians using principles of academic detailing in an evolving landscape.在不断变化的环境中,运用学术推广原则对社区临床医生进行培训。
Am J Health Syst Pharm. 2021 Jan 1;78(1):80-86. doi: 10.1093/ajhp/zxaa351.
4
Feasibility Study of a Quasi-experimental Regional Opioid Safety Prescribing Program in Veterans Health Administration Emergency Departments.退伍军人事务部急诊部准实验性区域阿片类药物安全处方方案的可行性研究。
Acad Emerg Med. 2020 Aug;27(8):734-741. doi: 10.1111/acem.13980. Epub 2020 May 12.
5
Educating Physicians in Family Medicine Residencies About Nonpharmacologic Approaches to Pain: Results of an Online Integrative Course.家庭医学住院医师的非药物治疗疼痛教育:在线综合课程的结果。
Fam Med. 2020 Feb 6;52(3):189-197. doi: 10.22454/FamMed.2020.865003.
6
Comparison of naloxone prescribing patterns due to educational outreach conducted by full-time and part-time academic detailers at the U.S. Veterans Health Administration.美国退伍军人事务部全职和兼职学术代表进行教育推广后纳洛酮处方模式的比较。
J Am Pharm Assoc (2003). 2020 Jul-Aug;60(4):639-646. doi: 10.1016/j.japh.2019.11.010. Epub 2019 Dec 20.
7
Changing prescribing behaviours with educational outreach: an overview of evidence and practice.改变教育推广下的处方行为:证据和实践概述。
BMC Med Educ. 2019 Aug 14;19(1):311. doi: 10.1186/s12909-019-1735-3.
8
Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration.学术细化对美国退伍军人健康管理局纳洛酮处方趋势的实施评估。
Health Serv Res. 2019 Oct;54(5):1055-1064. doi: 10.1111/1475-6773.13194. Epub 2019 Jul 17.
9
From the CDC: The Prevention for States program: Preventing opioid overdose through evidence-based intervention and innovation.美国疾病预防控制中心:预防药物过量国家项目:通过循证干预和创新预防阿片类药物过量。
J Safety Res. 2019 Feb;68:231-237. doi: 10.1016/j.jsr.2018.10.011. Epub 2018 Nov 4.
10
Academic Detailing for Postpartum Opioid Prescribing.学术详解产后阿片类药物处方。
J Am Board Fam Med. 2018 Nov-Dec;31(6):944-946. doi: 10.3122/jabfm.2018.06.180071.

理解美国 11 个州在实施开处方类阿片药物学术强化方面的州级差异。

Understanding State-Level Variations in Implementing Academic Detailing for Prescribing Opioids: Findings from 11 States Within the United States.

机构信息

Division of Overdose Prevention, National Center for Injury Prevention and Control, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

RTI International, Research Triangle Park, North Carolina, USA.

出版信息

Pain Med. 2022 Sep 30;23(10):1644-1653. doi: 10.1093/pm/pnac039.

DOI:10.1093/pm/pnac039
PMID:35218348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11215816/
Abstract

OBJECTIVE

Academic detailing is a clinical education technique characterized by targeted, one-on-one, interactive conversations between trained staff and the clinician. This study describes variations in implementing academic detailing among jurisdictions receiving funding from the U.S. Centers for Disease Control and Prevention (CDC) to prevent prescription drug overdoses.

DESIGN

In 2015, CDC started the Prescription Drug Overdose Prevention for States (PfS) program.

SUBJECTS

This study focuses on 11 of the 29 funded jurisdictions that implemented academic detailing as part of their PfS efforts.

METHODS

Jurisdictions provided annual progress reports from 2016 to 2019. We conducted semistructured interviews in 2017 and 2018 with all funded jurisdictions and conducted follow-up interviews with three jurisdictions in 2020 to obtain additional context. We used an analytic matrix display to identify themes from annual progress report data, the coding report from the 2017/2018 interviews, and the three follow-up interviews from 2020.

RESULTS

Two academic detailing models emerged: 1) one-on-one detailing, where centrally trained staff conducted all visits, and 2) a train-the-trainer model. Jurisdictions also described a hybrid model, which they referred to as academic detailing despite not meeting the definition of academic detailing. We identified variations in delivery strategies, staffing, and curriculum development within and between models. Despite these differences, common themes included the need to use data to focus academic detailing and the importance of partnerships.

CONCLUSIONS

Adoption of academic detailing as a strategy for improving opioid prescribing behaviors has increased. However, there is limited guidance and standardization to guide and evaluate implementation and outcomes.

摘要

目的

学术详述是一种临床教育技术,其特点是在经过培训的工作人员与临床医生之间进行有针对性的、一对一的互动对话。本研究描述了在美国疾病控制与预防中心(CDC)资助的 29 个司法管辖区中,实施学术详述以预防处方药物过量的情况存在差异。

设计

2015 年,CDC 启动了“预防州内处方药物过量(PfS)计划”。

研究对象

本研究重点关注了参与 PfS 计划的 29 个资助司法管辖区中的 11 个。

方法

各辖区在 2016 年至 2019 年期间提供了年度进展报告。我们在 2017 年和 2018 年对所有资助的辖区进行了半结构化访谈,并在 2020 年对三个辖区进行了后续访谈,以获取更多的背景信息。我们使用分析矩阵显示来确定年度进展报告数据、2017/2018 年访谈的编码报告以及 2020 年的三个后续访谈中的主题。

结果

出现了两种学术详述模型:1)一对一详述,由集中培训的工作人员进行所有访问;2)培训师模式。辖区还描述了一种混合模式,尽管不符合学术详述的定义,但他们称之为学术详述。我们在模型内和模型之间发现了交付策略、人员配备和课程开发方面的差异。尽管存在这些差异,但共同的主题包括需要使用数据来集中学术详述以及合作伙伴关系的重要性。

结论

作为改善阿片类药物处方行为的策略,学术详述的采用有所增加。然而,在指导和评估实施和结果方面,缺乏指导和标准化。